MSB 7.69% $1.19 mesoblast limited

Ann: Update on Novartis Agreement, page-53

  1. 40 Posts.
    lightbulb Created with Sketch. 7
    What was once a really promising, exciting business to be a part of has now become a shambles. Management clutching at straws to try and get the FDA to see their findings and convince them for approval. Bringing on more and more debt from aggressive PE/fund managers only brings less control.

    Seems like SI is in a bit too deep and all the walls falling down around him... Just saying, I'm sure I'm not alone in saying this stock has burnt a fair big hole in my pocket - gone are the days where this is a $5 stock
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.